Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Active, Not Recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

NCT03212404

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
Locations
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Buderim, Queensland, Australia
  • Research Site Greenslopes, Queensland, Australia
View all 48 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

NCT03553836

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • University of Arizona Cancer Center ( Site 0121) Tucson, Arizona, United States
  • UCSD Moores Cancer Center ( Site 0133) La Jolla, California, United States
  • The Angeles Clinic and Research Institute ( Site 0029) Los Angeles, California, United States
  • UCLA Hematology & Oncology ( Site 0130) Los Angeles, California, United States
View all 159 locations
View Trial Details
Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations
  • NGM Clinical Study Site Gilbert, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sarasota, Florida, United States
  • NGM Clinical Study Site Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

NCT04205227

Conditions
Adnexal Diseases, Cancer, Digestive System Diseases, +30 more
Locations
  • Cedars Sinai-The Angeles Clinic Los Angeles, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Border Medical Oncology Albury, New South Wales, Australia
  • Blacktown Oncology Blacktown, New South Wales, Australia
View Trial Details
Active, Not Recruiting

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

NCT05867303

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations
  • ICON Cancer Centre Wesley Auchenflower, Queensland, Australia
  • Southern Oncology Clinical Research Unit Bedford Park, South Australia, Australia
  • Cabrini Hospital Malvern Malvern, Victoria, Australia
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Active, Not Recruiting

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

NCT05013099

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Providence Saint John's Cancer Institute Santa Monica, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

NCT05270044

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Centro Oncologico Korben CABA, Buenos Aires, Argentina
  • Centro de Investigaciones Medicas Mar del Plata Mar del Plata, Buenos Aires, Argentina
  • Fundacion CIDEA Ciudad Autonoma Bs As, Ciudad Autonoma Buenos Aires, Argentina
  • Sanatorio Britanico S.A. Rosario, Santa Fe Province, Argentina
View all 155 locations
View Trial Details

Related conditions